introduction of sysmex
play

Introduction of Sysmex Sysmex Partec GmbH President & CEO - PowerPoint PPT Presentation

Introduction of Sysmex Sysmex Partec GmbH President & CEO Shinjiro Akamatsu Sysmex Group Overview Outline Head Office Chuo-ku, Kobe, Japan Established February 20, 1968 Paid-in Capital JPY12,276 million Consolidated Sales JPY


  1. Introduction of Sysmex Sysmex Partec GmbH President & CEO Shinjiro Akamatsu

  2. Sysmex Group Overview

  3. Outline Head Office Chuo-ku, Kobe, Japan Established February 20, 1968 Paid-in Capital JPY12,276 million Consolidated Sales JPY 281,935 million Subsidiaries and Affiliates 74 (Japan: 11 Overseas: 63) 8,445 (Japan: 3,517 Overseas: 4,928) Number of Employees *including part-time employees Development, manufacture, sales, import and export of diagnostics Main Lines of Business testing instruments and reagents, and related software SYS tematical ME dics + X Corporate name mean As of the end of March 2018 3

  4. History FY1995 FY2017 Overseas affiliates: 5 63 Product exports: 90 countries Over 190 countries Overseas sales ratio: Approx. 45% 84.0% Overseas employees: Approx. 250 (20%) 4,928 (58.4%) (100 million yen) 2013: Partnership w/Partec GmbH 3,000 9,000 2008: Established Technopark 1968: Established as a sales company 8,000 for TOA ELECTRIC (presently TOA) 2007: Established the “Sysmex Way” 2,500 7,000 1998: Company name change, and head office relocation 2,000 6,000 Global alliance 1995: Siemens / 1998: Roche 5,000 1995: Sysmex Deutschland for direct sales 1,500 4,000 1991: Sysmex UK for direct sales 1,000 3,000 1980: Sysmex Europe for customer support 2,000 1978: Launched the corporate brand name “Sysmex” 500 1,000 0 0 1968 1972 1976 1980 1984 1988 1992 1996 2000 2004 2008 2012 2016 Overseas sales Japan sales Number of Employees 4

  5. Business Segments Sales ratio by business Production Business Instruments Reagents ● Others ● Hematology ● ● Hematology ● Life Science 6.3% 3.2% ● ● Urinalysis ● ● ● Hemostasis Immunochemistry 62.0% 16.0% ○ ● Net Sales Clinical Chemistry \ 281.9 billion ● ○ Hemostasis ● Imm./ 5.2% 2018.3 F.Y. Chem. ● ● Life Science 7.3% ● ● ● Urinalysis Others ●: Own brand ○: Including other brands Instruments Reagents Maintenance service 5

  6. Positioning In Vitro Diagnostics *Sysmex estimate as of March 2016 1st: Sysmex Market Share 1st : Roche (Switz.) 2nd: Danaher (USA) 2nd : Danaher (USA) Hematology (Beckman Coulter) 3rd : Siemens (Germany) 3rd: Siemens (Germany) Hema- ・ tology Immuno- ・ chemisry ・ ・ Sysmex Others Urinalysis 7th: Sysmex (Urine sediment) 1st: Sysmex 2nd: Danaher (USA) *Sysmex estimate as of May 2018 Clinical *Sysmex estimates as of May 2018 (Iris) Chemistry 1st: Sysmex + Siemens (Germany) Hemostasis 2nd: IL (Spain) 3rd: Stago (France) Ranked in global top 10 as the only Asian based company 6

  7. Network (Global)  Export to more than 190 countries Sales ratio by region  63 overseas affiliates  84.0% of sales made in overseas markets AP Japan 8.8% *As of the end of March 2018 16.0% Sysmex Corporation (日本) China 25.6% 2018.3 F.Y. Americas 23.5% EMEA 26.2% Sysmex Shanghai Ltd. Sysmex Europe GmbH Sysmex Asia Pacific Pte Ltd. Sysmex America, Inc. 7

  8. Production Bases  Instruments production base: 4 base in Japan & 1 in Germany  Reagents production bases: 2 bases in Japan, 8 bases in overseas Germany Japan USA China Brazil India Singapore 8

  9. Strategy together with Partec GmbH

  10. Introduction of Sysmex Partec GmbH (SPG)

  11. Overview  Established in 1967  Joined Sysmex group in September, 2013  Headquarters: Görlitz, Germany  4 facilities in Germany (2 in Görlitz, 1 in Münster, 1 in Leipzig)  Headcount: 175 *as of July 2018  Certification: ISO9001:2015, ISO13485:2016 CE-IVD for IVD products, CE mark for non-IVD products WHO-Prequalification for CD4 solutions 11

  12. Facilities ( ): Head count # Flugplatz (13) Münster (21) Leipzig (7) Arndtstrasse (134) Görlitz (147) - 4 facilities in Germany - Münster: Customer facing function - Saxon area: Back office 12

  13. SPG Products Overview EHC (Essential Health Care) Reagents CyFlow Counter R&I-FCM (Research & Industrial FCM) CyFlow Space CyFlow Cube8 13 CyFlow PA Reagents & Consumables CyFlow Cube 6

  14. Advantages of SPG Development Optics technology Connection with researchers especially in EU region Support / funding by public organization Bio-cluster network in Saxon Production Precision machining and assembly by Meister Easy access to suppliers by good location at the middle of west and east Europe Support / funding by public organization 14

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend